Low doses of oral fludarabine in previously untreated elderly patients affected by chronic lymphocytic leukemia: Experience of a single unit

被引：0
|
作者：
Quirino, A. A. [1 ]
Villa, M. R. [1 ]
Improta, S. [1 ]
Lucania, A. [1 ]
Sagristani, M. [1 ]
Correale, F. [1 ]
Mastrullo, L. [1 ]
机构：
[1] PO San Gennaro, ASL NA1, UOC Ematol, Naples, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：116 / 116
页数：1
相关论文
共 50 条
  • [41] Chemoimmunotherapy with O-FC in previously untreated patients with chronic lymphocytic leukemia
    Wierda, William G.
    Kipps, Thomas J.
    Duerig, Jan
    Griskevicius, Laimonas
    Stilgenbauer, Stephan
    Mayer, Jiri
    Smolej, Lukas
    Hess, Georg
    Griniute, Rasa
    Hernandez-Ilizaliturri, Francisco J.
    Padmanabhan, Swaminathan
    Gorczyca, Michele
    Chang, Chai-Ni
    Chan, Geoffrey
    Gupta, Ira
    Nielsen, Tina G.
    Russell, Charlotte A.
    BLOOD, 2011, 117 (24) : 6450 - 6458
  • [42] Combination fludarabine, cyclophosphamide and rituximab for previously treated patients with chronic lymphocytic leukemia (CLL).
    Garcia-Manero, G
    O'Brien, S
    Cortes, J
    Giles, F
    Faderl, S
    Lerner, S
    Albitar, M
    Kantarjian, HM
    Keating, MJ
    BLOOD, 2000, 96 (11) : 757A - 757A
  • [43] Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997
    Flinn, Ian W.
    Neuberg, Donna S.
    Grever, Michael R.
    Dewald, Gordon W.
    Bennett, John M.
    Paietta, Elisabeth M.
    Hussein, Mohamad A.
    Appelbaum, Frederick R.
    Larson, Richard A.
    Moore, Dennis F., Jr.
    Tallman, Martin S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (07) : 793 - 798
  • [44] Therapy with fludarabine, cyclophosphamide and rituximab (FCR) for relapsed or untreated progressive chronic lymphocytic leukemia (CLL). A single center experience.
    Pavlovsky, Carolina
    Pavlovsky, Ntiago
    Pardo, Maria L.
    Sapia, Sandra
    Monreal, Maricla
    Corrado, Claudia
    Pavlovsky, Miguel A.
    Fernandez, Isolda
    Juni, Mariana
    BLOOD, 2006, 108 (11) : 329B - 329B
  • [45] Sequential therapy with fludarabine, high dose cyclophosphamide, and rituximab improves the quality of response in patients with previously untreated chronic lymphocytic leukemia.
    Weiss, MA
    Lamanna, N
    Gencarelli, A
    Scheinberg, DA
    Maslak, PG
    Horgan, D
    BLOOD, 2002, 100 (11) : 365B - 365B
  • [46] A Phase II Trial of Ofatumumab for Older Patients and Patients Who Refuse Fludarabine-Based Regimens with Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
    Flinn, Ian W.
    Harwin, William N.
    Macias-Perez, Ines M.
    Tucker, Patrick S.
    Waterhouse, David M.
    Papish, Steven W.
    Jones, Jeffrey A.
    Hainsworth, John D.
    Byrd, John C.
    BLOOD, 2011, 118 (21) : 1673 - 1673
  • [47] Oral fludarabine (FMP) is highly active in patients (pts) with previously untreated chronic lymphocytic leukemia (CLL), and leads to increased STAT1 levels in vivo.
    Friedberg, JW
    Dong, DA
    Li, SG
    Kim, H
    Stephans, K
    Noonan, K
    Neuberg, D
    Gribben, JG
    Freedman, AS
    Takvorian, T
    Battle, TE
    Frank, DA
    BLOOD, 2002, 100 (11) : 388A - 388A
  • [48] Phase I study of low-dose interleukin-2, fludarabine, and cyclophosphamide for previously untreated indolent lymphoma and chronic lymphocytic leukemia
    Kasamon, YL
    Flinn, IW
    Grever, MR
    Diehl, LF
    Garrett-Mayer, E
    Goodman, SN
    Lucas, MS
    Byrd, JC
    CLINICAL CANCER RESEARCH, 2005, 11 (23) : 8413 - 8417
  • [49] Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia
    Wierda, William G.
    O'Brien, Susan
    Wang, Xuemei
    Faderl, Stefan
    Ferrajoli, Alessandra
    Do, Kim-Anh
    Cortes, Jorge
    Thomas, Deborah
    Garcia-Manero, Guillermo
    Koller, Charles
    Beran, Miloslav
    Giles, Francis
    Ravandi, Farhad
    Lerner, Susan
    Kantarjian, Hagop
    Keating, Michael
    BLOOD, 2007, 109 (11) : 4679 - 4685
  • [50] A Multicenter Phase II Study Evaluating Fludarabine, Cyclophosphamide, and Subcutaneous Campath (FCCAM) for Previously Untreated Chronic Lymphocytic Leukemia
    Coutre, Steven E.
    Nabhan, Chadi
    BLOOD, 2014, 124 (21)
12345